ArticleHealth science reports2025
Red Blood Cell Distribution Width (RDW) as Predictor of the Clinical Course and Mortality in Patients With Acute Respiratory Distress Syndrome (ARDS): A Retrospective Study.
Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Evidence on the prognostic value of red blood cell distribution width (RDW) in critically ill patients with acute respiratory distress syndrome (ARDS) is limited. This study evaluated RDW as a predictor of mortality in patients with ARDS. Methods: A retrospective study conducted at an ARDS referral center included 1037 adult ICU patients (2007-2019). RDW values at ICU admission and during ICU stay were evaluated for their ability to predict mortality using statistical analyses, including logistic regression, Cox regression, and receiver operating curve analysis, and further specified according to Youden's method. Results: In total, 1037 ICU patients with ARDS were included in the analysis. Non-survivors had significantly higher RDW on ICU admission than survivors (survivors' median RDW 15.4% [14.2; 17.0%] vs. non-survivors' median RDW 16.55% [15.2; 18.0%]; Conclusion: RDW at ICU admission predicts mortality and clinical course in ARDS patients. RDW may serve as a reliable marker of ARDS severity and mortality risk in the ICU.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.